BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Jan 23, 15:49Prev. Close
91.38
Open Price
89.51
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Par Drugs & Chemicals (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 6.15 | 4.48 | 2.70 | 2.70 | 2.70 | |
| Total Share Capital | 6.15 | 4.48 | 8.45 | 8.45 | 8.45 | |
| Reserves and Surplus | 34.46 | 24.64 | 12.25 | 10.75 | 9.29 | |
| Total Reserves and Surplus | 34.46 | 24.64 | 12.25 | 10.75 | 9.29 | |
| Total Shareholders Funds | 40.61 | 29.12 | 20.70 | 19.20 | 17.74 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 4.62 | 6.03 | 13.07 | 14.30 | 15.85 | |
| Deferred Tax Liabilities [Net] | 3.65 | 3.42 | 3.24 | 2.70 | 1.95 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.39 | 0.33 | 0.26 | 0.24 | 0.00 | |
| Total Non-Current Liabilities | 8.66 | 9.78 | 16.57 | 17.25 | 17.80 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 0.00 | 4.32 | 5.08 | 6.53 | 10.00 | |
| Trade Payables | 6.20 | 4.93 | 5.26 | 7.78 | 6.70 | |
| Other Current Liabilities | 2.69 | 2.33 | 5.65 | 4.50 | 5.29 | |
| Short Term Provisions | 1.95 | 0.87 | 0.67 | 0.79 | 0.59 | |
| Total Current Liabilities | 10.84 | 12.46 | 16.67 | 19.59 | 22.57 | |
| Total Capital And Liabilities | 60.12 | 51.36 | 53.94 | 56.04 | 58.11 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 34.40 | 36.34 | 39.04 | 41.53 | 42.61 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.74 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 35.14 | 36.34 | 39.04 | 41.53 | 42.61 | |
| Non-Current Investments | 0.06 | 0.06 | 0.06 | 0.06 | 0.00 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.71 | 0.77 | 0.82 | 0.87 | 0.59 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 35.90 | 37.17 | 39.91 | 42.46 | 43.19 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 2.92 | 4.29 | 4.07 | 3.99 | 5.58 | |
| Trade Receivables | 12.37 | 8.52 | 8.72 | 8.11 | 7.38 | |
| Cash And Cash Equivalents | 7.38 | 0.03 | 0.06 | 0.02 | 0.93 | |
| Short Term Loans And Advances | 0.62 | 0.61 | 0.69 | 0.61 | 0.41 | |
| OtherCurrentAssets | 0.93 | 0.73 | 0.48 | 0.85 | 0.62 | |
| Total Current Assets | 24.22 | 14.18 | 14.03 | 13.58 | 14.92 | |
| Total Assets | 60.12 | 51.36 | 53.94 | 56.04 | 58.11 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.24 | 0.20 | 0.20 | 0.18 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.26 | 0.00 | 0.00 | 0.03 | 0.01 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 8.74 | -- | -- | -- | 0.86 | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 0.06 | 0.06 | 0.06 | 0.06 | -- | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
27.11.2025
Par Drugs Standalone September 2025 Net Sales at Rs 28.66 crore, down 17.31% Y-o-Y
22.08.2025
Par Drugs Standalone June 2025 Net Sales at Rs 26.05 crore, up 15.22% Y-o-Y
12.05.2025
Par Drugs Standalone March 2025 Net Sales at Rs 22.33 crore, down 2.14% Y-o-Y
23.10.2024
Par Drugs Standalone September 2024 Net Sales at Rs 34.66 crore, up 33.88% Y-o-Y
15.03.2018
24.04.2017
24.04.2017
20.04.2017